TACTILE SYSTEMS TECHNOLOGY INC
About TACTILE SYSTEMS TECHNOLOGY INC
Tactile Systems Technology, Inc. (Tactile Medical) is a medical technology company focused on developing and marketing at-home therapies for people suffering from underserved chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It offers products such as the Flexitouch Plus system and Entre Plus System, pneumatic compression devices for treatment of these conditions. The company is publicly traded on NASDAQ under ticker TCMD and is headquartered in Minneapolis, MN with 1086 employees.
- 🔗 Tactile Systems Technology, Inc. Announces Pricing of $32.5 Million Public Offering of Common Stock
- 🔗 Tactile Systems Technology, Inc. Announces Proposed Public Offering of Common Stock - Tactile Systems Technology, Inc.
- 🔗 tactile systems technology, inc.
- 🔗 Tactile Systems Technology, Inc. (NASDAQ:TCMD) is largely controlled by institutional shareholders who own 73% of the company
- 🔗 Tactile Systems Technology Inc Stock Price Today | NASDAQ: TCMD Live - Investing.com
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Completed $32.5M public offering of common stock in February 2023
- Products target lymphedema, lipedema, and chronic venous insufficiency
- 73% institutional ownership including 9.9% by BlackRock
- Net proceeds support commercial expansion, product development, and acquisitions
Ask StreetZero about TACTILE SYSTEMS TECHNOLOGY INC
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account